Pharmaceutical Technology

JANUARY 25, 2023

Development of PROTACs (PROteolysis TArgeting Chimeras) has advanced fairly rapidly as excitement grows over their potential to selectively degrade proteins that are involved in various diseases, including cancer. PROTACs are a type of heterobifunctional degrader that offers multiple advantages over traditional small molecules.

Protein 130

Protein Bioavailability Development Scientist 130

Pharmaceutical Technology

APRIL 28, 2023

Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026. Profile Syngene International Ltd.

Manufacturing 130

Manufacturing Antibody Clinical Supply Protein 130

XTalks

JULY 8, 2021

Along with a team of scientists, Kozubel fermented the microbe into a protein-rich substance and dubbed it “Fy.” While many faux meats tend to use soy, pea and other plant-based proteins, Fy is the foundation of Nature’s Fynd products. But is it safe to eat? The US Food and Drug Administration (FDA) says yes.

Protein 98

Protein Production Branding Marketing 98

Pharmaceutical Technology

JULY 7, 2022

But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. Often referred to as a type of gene-modified cell therapy, CAR-T cell therapies involve genetically modifying a patient’s own T cells to produce a protein that enables them to identify and kill cancer cells.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

Pharmaceutical Technology

FEBRUARY 22, 2023

Both drugs are monoclonal antibodies that inhibit the protein PCSK9. Amgen won the initial trial in March 2016 and Sanofi faced a potential withdrawal of Praluent from the US market. Developed by Sanofi and Regeneron, Praluent was approved by the FDA in July 2015. Amgen’s Repatha was greenlit a month later.

Antibody 262

Antibody Drugs Protein Sales 262

XTalks

NOVEMBER 8, 2021

Beans, soy, tofu, mushrooms and pea protein are some of the most common ingredients in meat analogues, but kelp could soon be added to that list. Aiming to solidify a prominent place in the booming plant-based meat market, AKUA came out with its first product in 2019 — Kelp Jerky. The global meat substitute market was valued at $4.51

Containment 98

Containment Protein Marketing Production 98

Bioengineer

JULY 20, 2021

Under the microscope, the untreated scars’ collagen – a protein produced by cells called fibroblasts – formed parallel strips, which makes the tissue less pliable. AlphaCT1 influences wound healing by temporarily interrupting cell signaling functions of connexin 43, a gap junction channel protein. Original Source.

Scientist 52

Scientist Engineer Research Clinical Trials 52

The Pharma Data

DECEMBER 1, 2020

The Single-Cell Intracellular Proteome chip provides a simple, integrated solution for monitoring simultaneous protein signaling networks that are missed by methods such as western blot, mass spectrometry, and flow cytometry. For more information about The Scientist ‘s 2020 Top 10 Innovations and the full list of winners, visit: [link].

Scientist 40

Scientist Protein Life Science Development 40

pharmaphorum

APRIL 19, 2022

[So] we are trying to go for the international market.”. “In Kim says the Dry Eye Disease market is large and growing, with analysts predicting it will hit $6 billion USD by 2025. David Julius, who discovered TRPV1 in 1997, was recognized with Nobel Prize in Medicine last year for his work with TRP proteins).

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52

Pharmaceutical Technology

AUGUST 24, 2022

More than three decades ago, scientists at the National Cancer Institute began exploring ways to fight cancer using the patient’s immune system. The global immunotherapy market, which includes CAR T-cell therapy, adoptive cell therapies, checkpoint inhibitors, monoclonal antibodies, and other immunotherapies, is expected to grow by 10.1%

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

JULY 14, 2021

Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only become activated when needed. Alborz Mahdavi. The platform could provide an alternative to the “ artificial pancreas ” systems, which use glucose-sensing devices coupled with insulin pumps.

Insulin 98

Insulin Protein Production Development 98

XTalks

MAY 5, 2021

Plant-based meat has come a long way since food tech got involved, but will any chef, scientist or a hybrid of the two be able to create the perfect plant-based marbled steak? This is one of the main reasons plant-based meat alternatives already on the market generally fall into the same categories.

Containment 105

Containment Production Protein Branding 105

XTalks

AUGUST 19, 2022

Scientists at the Zurich University of Applied Sciences (ZHAW) developed cell-based chocolate back in July 2021 to see what the future of food out of tanks might look like. The scientists also wanted to leave a light environmental footprint when they make the product.

Scientist 98

Scientist Production Protein Development 98

pharmaphorum

APRIL 1, 2021

“For example, you can simulate what would happen if you inhibited thousands of different proteins in thousands of different cell models.”. There are a lot of scientists who want to better understand biology but don’t have the money to do it in wet settings. So what do they do? They go into bioinformatics”. So, what do they do?

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

MARCH 1, 2021

COVID-19 antigen tests diagnose active infection by detecting SARS-CoV-2 viral proteins in samples, as opposed to PCR tests which detect viral RNA and require lab processing, but can miss infections with low virus levels.

In-Vitro 98

In-Vitro RNA Protein Antibody 98

XTalks

JULY 13, 2021

However, the plant-based chicken category has not hit the mainstream market until now. Additionally, per serving, they have 14 grams of protein, made mostly of fava bean, and have 40 percent less saturated fat than other tenders on the market. Beyond Meat has introduced Beyond Chicken Tenders to restaurants nationwide in the US.

Protein 52

Protein Marketing Production Hormones 52

pharmaphorum

DECEMBER 1, 2022

3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Etienne De Braekeleer, Senior Research Scientist, AstraZeneca. Billion by 2028. Dr Manjunath Hegde, Scientific Investigator & Associate Fellow, GSK.

In-Vitro 52

In-Vitro Scientist Engineer Gene Therapy 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic. Download this exclusive report here.

Vaccination 52

Vaccination Vaccine Protein Immune Response 52

Pharmaceutical Technology

FEBRUARY 23, 2023

Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. Quotient Sciences helps biotech and pharma customers in the development and optimization of drug products. Please check your email to download the Whitepaper.

Development 246

Development Drugs Bioavailability In-Vivo 246

pharmaphorum

JANUARY 11, 2023

To find potential drug candidates, disease-associated protein targets are tested against a small pool of less than ten million distinct chemotypes synthesised at great effort and expense over the past 100 years. Not an unambitious goal. Today’s pharmaceutical drug discovery process essentially relies on trial and error,” he expanded. “To

Big Data 122

Big Data Drugs Clinical Trials Clinical Trials 122

pharmaphorum

AUGUST 13, 2021

Six years ago, research scientist Inbal Zafir-Lavie tragically lost her 38-year-old sister Hava Zafir to colorectal cancer. What we are trying to do is characterise how does an ovarian cancer patient look like in terms of her proteins and her secretions, and our results show 89% accuracy,” says Inbal. The next big thing’.

Clinical Trials 105

Clinical Trials Clinical Trials Production Research 105

The Pharma Data

NOVEMBER 29, 2020

Wren possesses a novel network kinetics drug discovery platform that precisely quantifies the effects of small molecules on the protein misfolding and aggregation pathway that causes neurodegenerative diseases. synuclein for the treatment of debilitating protein misfolding disorders such as Parkinson’s disease.”. The accumulation of ?-synuclein

Research 52

Research Drugs Protein Development 52

XTalks

SEPTEMBER 8, 2020

“Our experience in drug product fill/finish will enable timely manufacturing to make the vaccine available as soon as possible to advance bringing life-changing medicines to market.”. The genetic material contains SARS-CoV-2 spike protein. The Phase 3 trial is being implemented as part of Operation Warp Speed.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

XTalks

JANUARY 28, 2021

Not only are the egg bites free of meat and dairy, but they are also GMO-free, cholesterol-free and contain a similar amount of protein as their animal-based counterparts at nine to 13 grams of protein, depending on the flavor.

Production 59

Production Protein Manufacturing Containment 59

Cloudbyz

MARCH 5, 2024

Biologics: Biologics are large, complex molecules, often proteins, that are produced using living cells. Mode of Action : Small Molecules: They often work by binding to specific sites on target proteins to inhibit or activate their function, which can affect various biological pathways inside the cell.

Development 97

Development Drugs Immune Response Manufacturing 97

The Pharma Data

DECEMBER 15, 2020

The Antigen ELISA is a laboratory test able to be applied in semi quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale. PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. About PerkinElmer.

Life Science 52

Life Science Protein Scientist Marketing 52

XTalks

APRIL 14, 2021

Scientists used synthetic biology and computational protein design tools to develop an enzymatic process to transform red cabbage anthocyanins into their desired color. After some research, they discovered that the treats did not look as vibrant as other children’s gummy snacks sold in the market.

Regulation 94

Regulation Production Branding Research 94

pharmaphorum

APRIL 21, 2022

One of the pathological features of Parkinson’s is the clumping of alpha-synuclein proteins in the central nervous system and a microscopic feature known as Lewy-type synucleinopathy (LTS) which is detected post-mortem by a immuno-histochemical (IHC) staining technique. versus 0.64. In January it raised $10.8

Protein 64

Protein Scientist Medicine Marketing 64

XTalks

MAY 5, 2021

Plant-based meat has come a long way since food tech got involved, but will any chef, scientist or a hybrid of the two be able to create the perfect plant-based marbled steak? This is one of the main reasons plant-based meat alternatives already on the market generally fall into the same categories.

Containment 52

Containment Production Protein Branding 52

The Pharma Data

JANUARY 12, 2021

The LumiraDx SARS-CoV-2 Antigen Test uses Fast Microfluidic Immunofluorescence (FMI) technology to detect antigen nucleocapsid protein from nasal or nasopharyngeal swabs with high sensitivity results in 12 minutes. Test specificity was 99.5% in nasal swab specimens. It has not been authorized for use to detect any other viruses or pathogens.

In-Vitro 52

In-Vitro Protein Scientist Manufacturing 52

pharmaphorum

OCTOBER 11, 2022

Tunnah began his career as a scientist, studying biochemistry right through to PhD at the University of Oxford, his work at that time concerning very early stage, novel anti-cancer therapies (or ‘structural biophysics’). And, actually, the answer in most cases is no. It’s much stronger when they work together in partnership,” he said.

Medicine 98

Medicine Pharma Companies Doctors Doctor 98

The Pharma Data

DECEMBER 21, 2020

Targeted protein degradation (TPD) is an approach whereby the body’s natural process for degrading proteins is diverted using small molecule drugs to eliminate disease-causing proteins. However, there has so far been limited progress in applying this exciting approach to membrane-associated proteins such as GPCRs.

Drugs 40

Drugs Protein Development Production 40

The Pharma Data

DECEMBER 10, 2020

Through its Genome5000 program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives.

Containment 52

Containment Clinical Development Development Protein 52

pharmaphorum

SEPTEMBER 28, 2022

Damour’s co-founders are ADC scientist Paul Jackson – formerly of King’s College London – who will serve as vice president of R&D, as well as Jackson’s former boss at KCL, Prof David Thurston, who will act as an advisor to the new company.

Antibody 52

Antibody Drugs Licensing Licensing 52

The Pharma Data

JANUARY 20, 2021

The LumiraDx SARS-CoV-2 Antigen Test is authorized for use by FDA under an Emergency Use Authorization (EUA) only for the detection of SARS-CoV-2 nucleocapsid protein. our Chief Scientist, who have a successful track record in building and scaling diagnostics businesses over three decades, including at companies such as Medisense, Inc.,

In-Vitro 52

In-Vitro Protein Scientist Manufacturing 52

The Pharma Data

NOVEMBER 1, 2020

For Product Enquiries and How to Order: All BD SARS-CoV-2 diagnostic products have regulatory authorizations in the markets where they are sold. The SARS-CoV-2 assay has been available in the United States since July through an Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).

In-Vitro 52

In-Vitro Production Protein Scientist 52

Delveinsight

AUGUST 20, 2020

Gilead is not likely to be able to refile until the next year, pushing it further behind its competitors for the JAK inhibitor market. Now, the scientists at the Salk Institute have found a potential solution to those problems. The FDA has also rejected Gilead’s filing for approval of filgotinib in rheumatoid arthritis.

Gene Therapy 52

Gene Therapy Research Gene Antibody 52